Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Atrazine Induces Reproductive Toxicity in an <i>In Vitro</i> Spermatogenesis (IVS) Model.

Biomedicines·2025

Same author

USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination.

Cancer biology & therapy·2025

Same author

Full genome characterization and evolutionary analysis of Banna virus isolated from <i>Culicoides</i>, <i>mosquitoes</i> and <i>ticks</i> in Yunnan, China.

Frontiers in cellular and infection microbiology·2023

Same author

Specific and Long-Term Luminescent Monitoring of Hydrogen Peroxide in Tumor Metastasis.

Advanced materials (Deerfield Beach, Fla.)·2023

Same author

Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey.

Aging brain·2023

Same author

Suppression of trinucleotide repeat expansion in spermatogenic cells in Huntington's disease.

Journal of assisted reproduction and genetics·2022

Search research articles

Related Experiment Video

Updated: May 2, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Cell-based therapies for Huntington's disease.

Yiju Chen¹, Richard L Carter², In K Cho²

¹Division of Neuropharmacology and Neurologic Diseases, Yerkes National Primate Research Center, 954 Gatewood Rd, NE Atlanta, GA 30329, USA; Department of Human Genetics, Emory University School of Medicine, 615 Michael St, Atlanta, GA 30322, USA.

Drug Discovery Today

|March 18, 2014

Summary

Cell-based therapies offer a promising future for Huntington's disease (HD) treatment. Induced pluripotent stem cells show potential for replacing lost neurons and improving motor function in HD rodent models.

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Published on: January 8, 2022

Related Experiment Videos

Last Updated: May 2, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Microtubule Plus-End Dynamics Visualization in Huntington's Disease Model based on Human Primary Skin Fibroblasts

Published on: January 8, 2022

Area of Science:

Neuroscience
Regenerative Medicine
Genetics

Background:

Huntington's disease (HD) involves progressive neurodegeneration, primarily affecting the striatum and cortex.
Current research explores genetic suppression of mutant huntingtin (mHTT) and cell replacement strategies for HD.

Purpose of the Study:

To evaluate the potential of cell-based therapies, specifically induced pluripotent stem cells (iPSCs), for treating Huntington's disease.

Main Methods:

Utilizing induced pluripotent stem cells (iPSCs) technology.
Differentiating iPSCs into neurons lost in HD models.
Assessing stem cell graft efficacy in improving motor deficits in rodent models.

Main Results:

iPSCs demonstrated the ability to differentiate into neurons relevant to HD pathology.
Stem cell grafts showed improvement in motor deficiencies in HD rodent models.

Conclusions:

Induced pluripotent stem cell technology shows significant promise for developing effective cell-based therapies for Huntington's disease.
These findings lay the groundwork for future clinical applications in HD treatment.